Allergen immunotherapy (desensitisation) for allergic diseases

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 6, Issue 4, 2006, Pages 348-351

  Durham, Stephen R ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Allergen immunotherapy; Allergic rhinitis; Desensitisation; Hayfever

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; RAGWEED ANTIGEN;

ALLERGIC DISEASE; ALLERGIC REACTION; APPLICATION SITE PAIN; APPLICATION SITE SWELLING; CLINICAL TRIAL; DESENSITIZATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; LONG TERM CARE; META ANALYSIS; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; TREATMENT OUTCOME;

EID: 33748085384     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.6-4-348     Document Type: Review

References (20)

1. Bousquet J, Lockey R, Mailing HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102(4 Pt 1): 558-62.
2. White P, Smith H, Webley F, Frew A. A survey of the quality of information leaflets on hayfever available from general practices and community pharmacies. Clin Exp Allergy 2004;34:1335-5.
3. Frew AJ, Powell RP, Corrigan CI, Durham SR; UK Immunotherapy Study Group. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:319-25.
4. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinits: a systematic review and meta-analysis. Am J Med 2004;116:338-44.
5. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Review. Cochrane Database Syst Rev 2003;(4):CD001186.
6. Committee on Safety of Medicines update: desensitising vaccines. BMJ 1986;293:948.
7. Hunt KI, Valentine MD, Sobotka AK et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299: 157-61.
8. Durham SR, Walker SM, Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341: 468-75.
9. Golden DB. Insect sting allergy and venom immunotherapy. Ann Allergy Asthma Immunol 2006;96(2 Suppl 1):S16-21.
10. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-7.
11. Moller C, Dreborg S, Ferdousi HA et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-6.
12. Till SJ, Francis JN, Nouri-Aria KT, Durham SR. Mechanisms of immunotherapy. Review. J Allergy Clin Immunol 2004;113: 1025-34.
13. Robinson DS, Larche M, Durham SR. Tregs and allergic disease. Review. J Clin Invest 2004;114:1389-97.
14. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. Review. J Allergy Clin Immunol 2003;111:437-48.
15. Wilson DR, Torres Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12.
16. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:802-9.
17. Oldfield WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002;360:47-53.
18. Jutel M, Jaeger L, Suck R et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608-13.
19. Francis JN, Durham SR. Adjuvants for allergen immunotherapy: experimental results and clinical perspectives. Curr Opin Allergy Clin Immunol 2004;4:543-8.
20. Casale TB, Busse WW, Kline JN et al; Immune Tolerance Network Group. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2006;117:134-40.